Literature DB >> 7903303

Targeted disruption of the mouse mdr1b gene reveals that steroid hormones enhance mdr gene expression.

S Altuvia1, W D Stein, S Goldenberg, S E Kane, I Pastan, M M Gottesman.   

Abstract

To evaluate the role of P-glycoprotein in steroid secretion in adrenal cells, we have used gene targeting to introduce a null mutation into one allele of the mdr1b gene in mouse Y1 adrenal cells. Characterization of both the wild-type and the mutant cell lines revealed the following. 1) The expression of mdr1b is enhanced by steroid hormones, in a feedback regulatory mechanism. Inhibition of steroid biosynthesis by 2-aminoglutethimide blocks the adrenocorticotropin (ACTH)-induced increase in mdr1b mRNA levels. 2) ACTH-stimulated steroid secretion is markedly decreased in the mutant cell line. This decreased steroid secretion in the mutant cells occurs despite an increase in the levels of mdr1b mRNA and P-glycoprotein. Kinetic analyses of vinblastine and daunomycin accumulation in both the wild-type and the mutant cell lines during ACTH-stimulated steroidogenesis show that in the mutant cells both drugs accumulated to higher levels than in Y1 cells, suggesting that the remaining mdr1b allele in the mutant cells is relatively inactive as an exporter of steroids, or that the targeted disruption of the mdr1b allele is associated with other changes in the mutant cells which block ACTH-stimulated steroid secretion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903303

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  The E23 early gene of Drosophila encodes an ecdysone-inducible ATP-binding cassette transporter capable of repressing ecdysone-mediated gene activation.

Authors:  T Hock; T Cottrill; J Keegan; D Garza
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  ATR-101 inhibits cholesterol efflux and cortisol secretion by ATP-binding cassette transporters, causing cytotoxic cholesterol accumulation in adrenocortical carcinoma cells.

Authors:  Veronica Elizabeth Burns; Tom Klaus Kerppola
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

Review 3.  The biology of the P-glycoproteins.

Authors:  C R Leveille-Webster; I M Arias
Journal:  J Membr Biol       Date:  1995-01       Impact factor: 1.843

4.  Induction of P-glycoprotein mRNA transcripts by cycloheximide in animal tissues: evidence that class I Pgp is transcriptionally regulated whereas class II Pgp is post-transcriptionally regulated.

Authors:  C H Lee
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

5.  A revised role for P-glycoprotein in the brain distribution of dexamethasone, cortisol, and corticosterone in wild-type and ABCB1A/B-deficient mice.

Authors:  Brittany L Mason; Carmine M Pariante; Sarah A Thomas
Journal:  Endocrinology       Date:  2008-06-12       Impact factor: 4.736

6.  Steroid biosynthesis and renal excretion in human essential hypertension: association with blood pressure and endogenous ouabain.

Authors:  Grazia Tripodi; Lorena Citterio; Tatiana Kouznetsova; Chiara Lanzani; Monica Florio; Rossana Modica; Elisabetta Messaggio; John M Hamlyn; Laura Zagato; Giuseppe Bianchi; Jan A Staessen; Paolo Manunta
Journal:  Am J Hypertens       Date:  2009-02-05       Impact factor: 2.689

7.  P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro.

Authors:  Winnie Y Kim; Leslie Z Benet
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

8.  The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar.

Authors:  J C Taylor; D R Ferry; C F Higgins; R Callaghan
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

9.  Multidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress.

Authors:  Christoph K Thoeringer; Thomas Wultsch; Anaid Shahbazian; Evelin Painsipp; Peter Holzer
Journal:  Psychoneuroendocrinology       Date:  2007-09-19       Impact factor: 4.905

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.